{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:34:18Z","timestamp":1788266058672,"version":"build-2803163510"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>This review aims to synthesize recent developments in the epidemiology of idiopathic inflammatory myopathies (IIMs), focusing on incidence, prevalence, disease classification, and clinical outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>IIM is a rare group of autoimmune diseases characterized by muscle weakness and systemic involvement, with incidence rates ranging from 0.2 to 2 cases per 100\u200a000 person-years. The role of myositis-specific autoantibodies (MSAs) in stratifying disease risk and prognosis is increasingly recognized, such as in anti-MDA5 positive DM, which is associated with a high risk of rapidly progressive interstitial lung disease. Furthermore, patients with IIM exhibit elevated risks of comorbidities, including cardiovascular disease and malignancy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>IIM diseases are complex disorders with significant health impacts, necessitating enhanced awareness and research. Improved classification and understanding of MSAs are crucial for earlier diagnosis and tailored therapeutic strategies. Continued epidemiological research is essential to elucidate underlying mechanisms and inform future interventions, ultimately aiming to enhance the quality of life and clinical outcomes for affected patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000001076","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T11:01:38Z","timestamp":1733828498000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Epidemiology of myositis"],"prefix":"10.1097","author":[{"given":"Fnu","family":"Duremala","sequence":"first","affiliation":[{"name":"Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Tiniakou","sequence":"additional","affiliation":[{"name":"Division of Rheumatology Medicine, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Andrews","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"R1-20241210","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20241210","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/B978-0-323-98818-6.00023-6","article-title":"Autoimmune inflammatory myopathies","volume":"195","author":"Dalakas","year":"2023","journal-title":"Handb Clin Neurol"},{"key":"R3-20241210","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41584-023-01033-0","article-title":"Epidemiology of the idiopathic inflammatory myopathies","volume":"19","author":"Khoo","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"R4-20241210","first-page":"591","article-title":"Global epidemiology of rheumatoid arthritis","volume":"18","author":"Finckh","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"R5-20241210","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","article-title":"The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies","volume":"56","author":"Rees","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R6-20241210","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/art.41964","article-title":"Performance of the 2017 European Alliance of Associations for Rheumatology\/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific Autoantibodies","volume":"74","author":"Casal-Dominguez","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R7-20241210","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R8-20241210","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R9-20241210","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/rheumatology\/kead481","article-title":"Comparison of clinical features between patients with antisynthetase syndrome and dermatomyositis: results from the MYONET registry","volume":"63","author":"Hum","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R10-20241210","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/acr.24786","article-title":"Incidence, prevalence, and mortality of dermatomyositis: a population-based cohort study","volume":"75","author":"Kronzer","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R11-20241210","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/jamadermatol.2022.3112","article-title":"Incidence of dermatomyositis in a nationwide cohort study of US Veterans","volume":"158","author":"Bolender","year":"2022","journal-title":"JAMA Dermatol"},{"key":"R12-20241210","doi-asserted-by":"crossref","first-page":"e552","DOI":"10.1097\/RHU.0000000000001736","article-title":"Epidemiology of idiopathic inflammatory myopathies in Africa: a contemporary systematic review","volume":"28","author":"Essouma","year":"2022","journal-title":"J Clin Rheumatol"},{"key":"R13-20241210","first-page":"1333","article-title":"The prevalence, epidemiological characteristics and mortality trends of inflammatory myopathies patients in Oman: the Prevision study","volume":"42","author":"Al Adhoubi","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"R14-20241210","doi-asserted-by":"crossref","first-page":"1319957","DOI":"10.3389\/fimmu.2023.1319957","article-title":"Disease patterns and specific trajectories of anti-MDA5-related disease: a multicentre retrospective study of 70 adult patients","volume":"14","author":"de Boysson","year":"2023","journal-title":"Front Immunol"},{"key":"R15-20241210","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11926-024-01164-7","article-title":"Recent updates on the pathogenesis of inflammatory myopathies","volume":"26","author":"Musai","year":"2024","journal-title":"Curr Rheumatol Rep"},{"key":"R16-20241210","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41584-023-01045-w","article-title":"International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative","volume":"19","author":"Oldroyd","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"R17-20241210","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/art.42474","article-title":"Association of anti-CCAR1 autoantibodies with decreased cancer risk relative to the general population in patients with anti-transcriptional intermediary factor 1gamma-positive dermatomyositis","volume":"75","author":"Fiorentino","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R19-20241210","first-page":"309","article-title":"Anti-MDA5-positive dermatomyositis and remission in a single referral centre population","volume":"41","author":"Tiniakou","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"R20-20241210","doi-asserted-by":"crossref","first-page":"152231","DOI":"10.1016\/j.semarthrit.2023.152231","article-title":"Risk factors for mortality in patients with anti-MDA5 antibody-positive dermatomyositis: A meta-analysis and systematic review","volume":"62","author":"Xie","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"R21-20241210","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/BOR.0000000000000837","article-title":"Polymyositis: does it really exist as a distinct clinical subset?","volume":"33","author":"Leclair","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"R22-20241210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ana.26412","article-title":"Epidemiology, survival, and clinical characteristics of inclusion body myositis","volume":"92","author":"Lindgren","year":"2022","journal-title":"Ann Neurol"},{"key":"R23-20241210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nmd.2024.03.001","article-title":"272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16-18 June 2023, Hoofddorp, The Netherlands","volume":"37","author":"Lilleker","year":"2024","journal-title":"Neuromuscul Disord"},{"key":"R24-20241210","doi-asserted-by":"crossref","first-page":"e1406","DOI":"10.1212\/WNL.0000000000206777","article-title":"Clinical subgroups and factors associated with progression in patients with inclusion body myositis","volume":"100","author":"Michelle","year":"2023","journal-title":"Neurology"},{"key":"R25-20241210","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1007\/s00415-023-11878-w","article-title":"Inclusion body myositis with early onset: a population-based study","volume":"270","author":"Lindgren","year":"2023","journal-title":"J Neurol"},{"key":"R26-20241210","doi-asserted-by":"crossref","first-page":"e2653","DOI":"10.1212\/WNL.0000000000012004","article-title":"Epidemiology and natural history of inclusion body myositis: a 40-year population-based study","volume":"96","author":"Shelly","year":"2021","journal-title":"Neurology"},{"key":"R27-20241210","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10067-022-06404-8","article-title":"Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China","volume":"42","author":"Wang","year":"2023","journal-title":"Clin Rheumatol"},{"key":"R28-20241210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","article-title":"The EuroMyositis registry: an international collaborative tool to facilitate myositis research","volume":"77","author":"Lilleker","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R29-20241210","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.semarthrit.2020.09.020","article-title":"Antisynthetase syndrome - much more than just a myopathy","volume":"51","author":"Opinc","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"R30-20241210","doi-asserted-by":"crossref","first-page":"e15261","DOI":"10.1111\/1756-185X.15261","article-title":"Antisynthetase syndrome in South Australia over 13\u200ayears: a clinical descriptive study","volume":"27","author":"Ali","year":"2024","journal-title":"Int J Rheum Dis"},{"key":"R31-20241210","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/ard-2023-225284","article-title":"Novel endotypes of antisynthetase syndrome identified independent of antiaminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification","volume":"83","author":"Wu","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"R32-20241210","doi-asserted-by":"crossref","first-page":"103286","DOI":"10.1016\/j.jaut.2024.103286","article-title":"Immune-mediated necrotizing myopathy: a comprehensive review of the pathogenesis, clinical features, and treatments","volume":"148","author":"Li","year":"2024","journal-title":"J Autoimmun"},{"key":"R33-20241210","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/rheumatology\/keae284","article-title":"Breaking down statin myopathy: understanding the self-limited and autoimmune subtypes","volume":"63","author":"Wright","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R34-20241210","doi-asserted-by":"crossref","first-page":"103468","DOI":"10.1016\/j.autrev.2023.103468","article-title":"Anti-HMGCR immune-mediated necrotising myopathy: addressing the remaining issues","volume":"22","author":"Khoo","year":"2023","journal-title":"Autoimmun Rev"},{"key":"R35-20241210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12890-021-01802-1","article-title":"Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with antisignal recognition particle antibodies","volume":"22","author":"Ge","year":"2022","journal-title":"BMC Pulm Med"},{"key":"R36-20241210","doi-asserted-by":"crossref","first-page":"152522","DOI":"10.1016\/j.semarthrit.2024.152522","article-title":"Anti-HMGCR myopathy: diversity of clinical presentations in a national cohort in New Zealand","volume":"68","author":"Chow","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"R37-20241210","doi-asserted-by":"crossref","first-page":"570","DOI":"10.31138\/mjr.220823.imc","article-title":"A challenging inflammatory myopathy case-report: dermatomyositis-like rash in an anti-HMGCR positive patient with an uncertain muscle histology","volume":"34","author":"Parente","year":"2023","journal-title":"Mediterr J Rheumatol"},{"key":"R38-20241210","doi-asserted-by":"crossref","first-page":"102691","DOI":"10.1016\/j.jaut.2021.102691","article-title":"Cutaneous involvement in anti-HMGCR positive necrotizing myopathy","volume":"123","author":"Williams","year":"2021","journal-title":"J Autoimmun"},{"key":"R39-20241210","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keae282","article-title":"Anti-HMGCR myopathy: estimated five-fold higher incidence in Polynesian compared to European populations in Aotearoa New Zealand","author":"Chow","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R40-20241210","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/mus.27504","article-title":"Incidence and prevalence of immune-mediated necrotizing myopathy in adults in Olmsted County, Minnesota","volume":"65","author":"Shelly","year":"2022","journal-title":"Muscle Nerve"},{"key":"R41-20241210","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejim.2022.04.017","article-title":"Epidemiological and genetic features of anti3-hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: single-center experience and literature review","volume":"101","author":"Prieto-Pena","year":"2022","journal-title":"Eur J Intern Med"},{"key":"R42-20241210","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.42126","article-title":"Increased risk of statin-associated autoimmune myopathy among American Indians","volume":"74","author":"Wei","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R44-20241210","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1080\/1744666X.2023.2238128","article-title":"Inflammatory myopathy in adults, health-related quality of life, and wellbeing: a round trip between immune disease and wellness","volume":"19","author":"Armadans-Tremolosa","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"key":"R45-20241210","first-page":"413","article-title":"Mental health in paediatric and adult myositis-related diseases: current state of research, interventions, and future steps from the MIHRA Psychological Impact Scientific Working Group","volume":"42","author":"Lanis","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"R46-20241210","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/rheumatology\/keac441","article-title":"Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey","volume":"62","author":"Yoshida","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"R47-20241210","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.nmd.2023.10.017","article-title":"The personal financial burden associated with idiopathic inflammatory myopathies","volume":"33","author":"Hua","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"R48-20241210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s13023-023-02902-3","article-title":"Cost of illness in inclusion body myositis: results from a cross-sectional study in Germany","volume":"18","author":"Senn","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"R49-20241210","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s10067-023-06633-5","article-title":"Assessment of cardiovascular risk factors in patients with idiopathic inflammatory myopathies: a systematic review","volume":"42","author":"Goncalves Junior","year":"2023","journal-title":"Clin Rheumatol"},{"key":"R50-20241210","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1007\/s10067-024-07109-w","article-title":"Atherosclerotic cardiovascular disease following a diagnosis of idiopathic inflammatory myopathy: analysis from a retrospective cohort in the TriNetX registry","volume":"43","author":"Allenzara","year":"2024","journal-title":"Clin Rheumatol"},{"key":"R51-20241210","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/rheumatology\/kead271","article-title":"Cardiovascular risk in myositis patients compared with the general population","volume":"63","author":"Oreska","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R52-20241210","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1093\/rheumatology\/keab851","article-title":"Cardiovascular events in adult polymyositis and dermatomyositis: a meta-analysis of observational studies","volume":"61","author":"Xiong","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R53-20241210","doi-asserted-by":"crossref","first-page":"928861","DOI":"10.3389\/fimmu.2022.928861","article-title":"Myocardial involvement is not rare in antimelanoma differentiation-associated gene 5 antibody-positive dermatomyositis\/clinically amyopathic dermatomyositis: a retrospective study","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Immunol"},{"key":"R54-20241210","doi-asserted-by":"crossref","first-page":"1094611","DOI":"10.3389\/fimmu.2023.1094611","article-title":"Characteristics of cardiac involvement in immune-mediated necrotizing myopathy","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"R55-20241210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00296-022-05214-0","article-title":"Long-term risks of malignancy in myositis-specific antibody-positive idiopathic inflammatory myopathy","volume":"43","author":"Izuka","year":"2023","journal-title":"Rheumatol Int"},{"key":"R56-20241210","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/art.42311","article-title":"Subsets of idiopathic inflammatory myositis enriched for contemporaneous cancer relative to the general population","volume":"75","author":"Mecoli","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R57-20241210","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1001\/jamadermatol.2024.3355","article-title":"Application of risk-based cancer screening in patients with dermatomyositis","volume":"160","author":"Stone","year":"2024","journal-title":"JAMA Dermatol"},{"key":"R58-20241210","doi-asserted-by":"crossref","first-page":"152283","DOI":"10.1016\/j.semarthrit.2023.152283","article-title":"Obesity is an independent risk factor for cancer development following diagnosis of dermatomyositis","volume":"64","author":"Allenzara","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"R59-20241210","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/ard-2022-222441","article-title":"Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1gamma autoantibodies","volume":"82","author":"Hosono","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R60-20241210","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.3390\/jcm13144055","article-title":"A review of myositis-associated interstitial lung disease","volume":"13","author":"Kannappan","year":"2024","journal-title":"J Clin Med"},{"key":"R61-20241210","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/art.42860","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"R62-20241210","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1093\/rheumatology\/kead006","article-title":"WDFY4 polymorphisms in Chinese patients with anti-MDA5 dermatomyositis is associated with rapid progressive interstitial lung disease","volume":"62","author":"Guo","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"R63-20241210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13075-023-03243-z","article-title":"Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis","volume":"26","author":"Qiu","year":"2024","journal-title":"Arthritis Res Ther"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T11:01:58Z","timestamp":1733828518000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":61,"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001076","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,11]]}}}